Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Mitozolomide> ?p ?o. }
Showing items 1 to 49 of
49
with 100 items per page.
- Mitozolomide abstract "Mitozolomide (INN) is an antineoplastic. It is an imidazotetrazine derivative.Development of mitozolomide was discontinued during Phase II clinical trials after it was found to cause severe and unpredictable bone marrow suppression. Temozolomide, which has been in clinical use since 1999, is a less toxic analogue of mitozolomide.".
- Mitozolomide atcPrefix "none".
- Mitozolomide casNumber "85622-95-3".
- Mitozolomide fdaUniiCode "E3U7286V3W".
- Mitozolomide iupacName "3-(2-chloroethyl)-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide".
- Mitozolomide pubchem "71766".
- Mitozolomide thumbnail Mitozolomide.svg?width=300.
- Mitozolomide wikiPageID "21261240".
- Mitozolomide wikiPageRevisionID "592520533".
- Mitozolomide atcPrefix "none".
- Mitozolomide c "7".
- Mitozolomide casNumber "85622".
- Mitozolomide chembl "435951".
- Mitozolomide cl "1".
- Mitozolomide h "7".
- Mitozolomide hasPhotoCollection Mitozolomide.
- Mitozolomide iupacName "3".
- Mitozolomide molecularWeight "242.622".
- Mitozolomide n "6".
- Mitozolomide o "2".
- Mitozolomide pubchem "71766".
- Mitozolomide smiles "NCc1ncn2CN\N=N/c12".
- Mitozolomide unii "E3U7286V3W".
- Mitozolomide verifiedfields "changed".
- Mitozolomide verifiedrevid "376147382".
- Mitozolomide watchedfields "changed".
- Mitozolomide subject Category:Experimental_cancer_drugs.
- Mitozolomide type Agent114778436.
- Mitozolomide type Antineoplastic102722458.
- Mitozolomide type CausalAgent100007347.
- Mitozolomide type CytotoxicDrug103157987.
- Mitozolomide type Drug103247620.
- Mitozolomide type ExperimentalCancerDrugs.
- Mitozolomide type Matter100020827.
- Mitozolomide type Medicine103740161.
- Mitozolomide type PhysicalEntity100001930.
- Mitozolomide type Substance100020090.
- Mitozolomide type Drug.
- Mitozolomide type DrugProduct.
- Mitozolomide type FunctionalSubstance.
- Mitozolomide comment "Mitozolomide (INN) is an antineoplastic. It is an imidazotetrazine derivative.Development of mitozolomide was discontinued during Phase II clinical trials after it was found to cause severe and unpredictable bone marrow suppression. Temozolomide, which has been in clinical use since 1999, is a less toxic analogue of mitozolomide.".
- Mitozolomide label "Mitozolomide".
- Mitozolomide sameAs m.05c4k9s.
- Mitozolomide sameAs Q6881926.
- Mitozolomide sameAs Q6881926.
- Mitozolomide sameAs Mitozolomide.
- Mitozolomide wasDerivedFrom Mitozolomide?oldid=592520533.
- Mitozolomide depiction Mitozolomide.svg.
- Mitozolomide isPrimaryTopicOf Mitozolomide.